Related Experiment Video
Updated: Aug 15, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters
1Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. pany@mskcc.org
Abstract:
Mu opioid receptors play an important role in mediating the actions of a class of opioids including morphine and heroin. Binding and pharmacological studies have proposed several mu opioid receptor subtypes: mu(1), mu(2), and morphine-6beta-glucuronide (M6G). The cloning of a mu opioid receptor, MOR-1, has provided an invaluable tool to explore pharmacological and physiological functions of mu opioid receptors at the molecular level. However, only one mu opioid receptor (Oprm) gene has been isolated. Alternative pre-mRNA splicing has been proposed as a molecular explanation for the existence of pharmacologically identified subtypes. In recent years, we have extensively investigated alternative splicing of the Oprm gene, particularly of the mouse Oprm gene. So far we have identified 25 splice variants from the mouse Oprm gene, which are controlled by two diverse promoters, eight splice variants from the rat Oprm gene, and 11 splice variants from the human Oprm gene. Diversity and complexity of the Oprm gene was further demonstrated by functional differences in agonist-induced G protein activation, adenylyl cyclase activity, and receptor internalization among carboxyl terminal variants. This review summarizes these recent results and provides a new perspective on understanding and exploring complex opioid actions in animals and humans.
Insights
The mu opioid receptor (Oprm) gene exhibits extensive alternative splicing, generating numerous variants in mice, rats, and humans. These splice variants display functional differences, contributing to the complexity of opioid actions.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Mu opioid receptors mediate the effects of opioids like morphine and heroin.
- Pharmacological studies suggested multiple mu opioid receptor subtypes.
- The cloning of MOR-1 provided a molecular tool, but only one Oprm gene was initially identified.
Purpose of the Study:
- To investigate alternative splicing of the Oprm gene.
- To understand the molecular basis for mu opioid receptor diversity.
- To explore functional differences among Oprm splice variants.
Main Methods:
- Analysis of Oprm gene alternative pre-mRNA splicing in mouse, rat, and human.
- Identification and characterization of Oprm splice variants.
- Functional assays measuring G protein activation, adenylyl cyclase activity, and receptor internalization.
Main Results:
- Identified 25 splice variants from the mouse Oprm gene, 8 from rat, and 11 from human.
- Oprm gene splicing is controlled by two distinct promoters.
- Carboxyl-terminal variants exhibit functional differences in signaling pathways and receptor trafficking.
Conclusions:
- Alternative splicing of the Oprm gene generates significant molecular diversity.
- This diversity contributes to the complex pharmacological actions of opioids.
- Findings offer a new perspective on understanding opioid effects in humans and animals.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
What is Gene Expression?

